Transdifferentiation is a complete and stable change in cell identity that serves as an alternative to stem-cell-mediated organ regeneration. In adult mammals, findings of transdifferentiation have been limited to the replenishment of cells lost from preexisting structures, in the presence of a fully developed scaffold and niche 1 .
.
Here we show that transdifferentiation of hepatocytes in the mouse liver can build a structure that failed to form in development-the biliary system in a mouse model that mimics the hepatic phenotype of human Alagille syndrome (ALGS) 2 . In these mice, hepatocytes convert into mature cholangiocytes and form bile ducts that are effective in draining bile and persist after the cholestatic liver injury is reversed, consistent with transdifferentiation. These findings redefine hepatocyte plasticity, which appeared to be limited to metaplasia, that is, incomplete and transient biliary differentiation as an adaptation to cell injury, based on previous studies in mice with a fully developed biliary system [3] [4] [5] [6] . In contrast to bile duct development 7-9 , we show that de novo bile duct formation by hepatocyte transdifferentiation is independent of NOTCH signalling. We identify TGFβ signalling as the driver of this compensatory mechanism and show that it is active in some patients with ALGS. Furthermore, we show that TGFβ signalling can be targeted to enhance the formation of the biliary system from hepatocytes, and that the transdifferentiation-inducing signals and remodelling capacity of the bile-duct-deficient liver can be harnessed with transplanted hepatocytes. Our results define the regenerative potential of mammalian transdifferentiation and reveal opportunities for the treatment of ALGS and other cholestatic liver diseases.
In regenerating organs of adult mammals, differentiated cells can replenish other types of differentiated cells by transdifferentiation, as in the pancreatic islet 10 , gastric gland 11 , lung alveolus 12 and intestinal crypt 13 . Whether mammalian transdifferentiation can build these or other structures de novo is unknown. In the liver, hepatocytes can undergo biliary differentiation to form reactive ductules both in humans [14] [15] [16] [17] and animals with cholestatic liver injury [3] [4] [5] [6] [18] [19] [20] [21] . However, hepatocyte-derived biliary cells exhibit incomplete biliary and residual hepatocyte differentiation, that is, they are not mature cholangiocytes, and revert back to their original identity after the injury is reversed [3] [4] [5] [6] . Moreover, hepatocyte-derived ductules do not contribute to bile drainage 5 . These findings are consistent with metaplasia, but not with transdifferentiation, and call into question the functional importance of hepatocyte plasticity. However, all studies of hepatocyte plasticity published so far used animals with a fully developed biliary system in which residual cholangiocytes are available to regenerate injured bile ducts, probably leading to insufficient pressure for transdifferentiation. To determine the full extent of hepatocyte plasticity, we used mice that lack the intrahepatic biliary system. Specifically, we used mice that mimic the hepatic phenotype of ALGS-a human disease caused by impaired NOTCH signalling [22] [23] [24] generated by deletion of floxed alleles of the NOTCH signalling effector RBPJ and, to prevent compensation 25 , the transcription factor HNF6 (also known as ONECUT1) in embryonic liver progenitors using Cre expressed from an albumin (Alb) promoter 2 . These Alb-cre
Hnf6
f/f mice are severely cholestatic because they lack peripheral bile ducts (pBDs), the branches of the intrahepatic biliary tree, at birth; however, more than 90% of the mice survive and form pBDs and a functional biliary tree by postnatal day (P) 120 26 ( Fig. 1a) . Although Alb-cre
f/f mice have hilar bile ducts (hBDs), the trunk of the biliary tree, we hypothesized that the new pBDs originate from hepatocytes because the livers of Alb-cre
f/f mice contain hybrid cells that express hepatocyte and biliary markers 2, 26 . To test this hypothesis, we developed Cre-independent hepatocyte fate tracing. For this, we activated the Flp-reporter (GFP) in R26ZG +/+ mice specifically in hepatocytes by intravenous injection of an adeno-associated virus (AAV) serotype 8 vector expressing Flp from the transthyretin (Ttr) promoter (AAV8-Ttr-Flp) ( Fig. 1a and Extended Data Fig. 1a-g ).
To trace hepatocytes during pBD formation, we intravenously injected Alb-cre 
R26ZG
+/+ mice with AAV8-Ttr-Flp at P17, which is before cells expressing biliary markers emerge in the liver periphery 2, 26 . At P120, the newly formed pBDs, identified by wide-spectrum (ws) cytokeratin (CK) immunofluorescence, were GFP positive, indicating hepatocyte origin (Fig. 1a, b) . By contrast, pBDs that formed normally during liver development in Cre-negative littermates were GFP negative (Extended Data Fig. 2a, b) . In many pBDs of Alb-cre 
+/+ mice, all cells were GFP positive, whereas the overall labelling efficiency of peripheral cholangiocytes was 39.2 ± 7.2% (mean ± s.e.m.); however, this number correlated well with the hepatocyte labelling efficiency (36.6 ± 4.8%; P = 0.48, paired two-sided Student's t-test) (Extended Data Fig. 2c ), indicating that all peripheral cholangiocytes originated from hepatocytes. We also observed hepatocyte-derived peripheral cholangiocytes in mice in which hepatocytes were labelled after weaning (P39) (Extended Data Fig. 2d, e) . These results show that hepatocytes can form pBDs de novo.
To investigate the function of the hepatocyte-derived pBDs (HpBDs), we determined whether they are contiguous with the extrahepatic biliary system. At P30, retrograde ink injection into the common bile duct filled only hBDs, reflecting a severely truncated biliary tree that lacked pBDs; however, ink injection at ≥P120 revealed a biliary tree of Letter reSeArCH normal dimensions, demonstrating that HpBDs are connected to hBDs (Fig. 1c) . Three-dimensional (3D) reconstruction of confocal imaging confirmed that HpBDs form contiguous lumens with dolichos biflorus agglutinin (DBA)-labelled hBDs ( Fig. 1d and Supplementary Video 1) . Accordingly, HpBDs were effective in draining bile, as evidenced by normalization of serum markers of cholestasis (total bilirubin and alkaline phosphatase levels; Extended Data Fig. 3a-c ) and hepatocyte injury (alanine aminotransferase and aspartate aminotransferase levels; Extended Data Fig. 3d , e) and resolution of cholestasis-induced liver fibrosis (Sirius red staining; Extended Data Fig. 3f ). A few mice that continued to have increased levels of serum total bilirubin and liver fibrosis showed abundant wsCK-positive hepatocytes but no HpBDs (Extended Data Fig. 3a, b, g ). In contrast to the transient hepatocytederived ductules observed in other mouse models of cholestatic liver injury [3] [4] [5] [6] , HpBDs were stable beyond the time when cholestasis and liver injury were resolved and were maintained for life (≥P334) (Fig. 1c, e) . These results show that HpBDs provide normal and stable biliary function.
We also investigated the authenticity and maturity of the cholangiocytes that form the HpBDs. The cells displayed acetylated tubulinmarked primary cilia (Fig. 2a) , indicating a switch from hepatocyte to biliary fate 19 , and somatostatin receptor 2 (SSTR2) (Fig. 2b) , a marker of biliary function 27 . They also expressed the mature biliary markers epithelial cell adhesion molecule (EPCAM) and CK19 (Fig. 2c) , which are lacking or expressed at low levels in hepatocyte-derived metaplastic biliary cells 3, 5 . To substantiate these results, we performed RNA-sequencing (RNA-seq) analysis on hepatocyte-derived peripheral cholangiocytes isolated as EPCAM-positive DBA-negative cells by FACS from >P115 Alb-cre Data  Fig. 4a ). Rbpj and Hnf6 were deleted in these cells (Extended Data  Fig. 4b, c) , which was expected because Alb-cre is active in embryonic liver progenitors before they commit to hepatocyte or biliary fate 2, 9 . Principal component analysis showed that hepatocyte-derived peripheral cholangiocytes cluster closely with normal peripheral cholangiocytes isolated from Cre-negative littermates, but not with parental hepatocytes (Fig. 2d , e and Supplementary Table 1) . Accordingly, hepatocyte-derived peripheral cholangiocytes expressed normal levels of mature biliary markers that are virtually undetectable in 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet-induced hepatocyte-derived metaplastic biliary cells 3 , except for CFTR, which is less enriched in cholangiocytes than the other markers (Fig. 2f) . Hepatocyte-derived peripheral cholangiocytes also expressed other commonly used markers of biliary differentiation 3, 5, 20, 25, 27, 28 at normal or near-normal levels (Fig. 2f) , and showed virtually no memory of hepatocyte differentiation 3, 29, 30 ( Fig. 2g and Extended Data Fig. 4d ). These results show that hepatocyte-derived peripheral cholangiocytes are authentic and mature peripheral cholangiocytes.
Next, we investigated the contribution of proliferation to HpBD formation, and sought to determine whether a few hepatocytes proliferate extensively after transdifferentiation, or whether many hepatocytes transdifferentiate. For this, we measured clonal expansion in HpBDs by sparsely labelling hepatocytes in Alb-cre
+/+ mice with low-dose AAV8-Ttr-Flp at P18 and quantifying the cells in GFP-positive clones at P120 (Fig. 3a) . Surprisingly, we found only 1.56 ± 0.05 cells per clone in HpBDs, with one-cell clones accounting for 63.8 ± 3.6% of clones. To exclude the possibility that the nonintegrating AAV vector missed proliferating hepatocytes, we analysed clone size in Alb-cre 
. c, Biliary tree visualized by retrograde ink injection into the common bile duct of P30 (n = 6), P120-P138 (n = 6) and ≥P334 (n = 6) Alb-cre +/− Rbpj f/f Hnf6 f/f mice, and P30 (n = 3) and P120-P138 (n = 5) 
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and are thus polyclonal, and confirm that hilar cholangiocytes do not contribute to HpBD formation.
Unlike in HpBDs, we found significant proliferation in hepatocyte-derived reactive ductules, which are detectable in Alb-cre
Hnf6
f/f R26ZG +/+ mice during cholestasis (Extended Data Fig. 5b ). Clonal analysis showed 2.70 ± 0.08 cells per clone in reactive ductules in P90 Alb-cre
R26R-Confetti
+/− mice, with more threeand four-cell clones than in pBDs in Alb-cre Data Fig. 5c ). Because HpBDs form with little proliferation, we reasoned that these proliferating cells are hepatocyte-derived metaplastic biliary cells [3] [4] [5] [6] . Indeed, we found that 93.51 ± 0.81% of the proliferating biliary cells identified by KI67 and osteopontin (OPN) immunofluorescence in Alb-cre
Hnf6
f/f mice near the peak of cholestasis (P54) were CK19 negative (Extended Data Fig. 5d ).
We also investigated proliferation in established HpBDs by inducing cholestatic liver injury with a DDC diet in >P120 Alb-cre
Hnf6 f/f mice. Reactive ductules formed 2 weeks later than in Cre-negative littermates, and consisted mainly of OPN-positive EPCAM-negative cells, indicative of hepatocyte metaplasia (Extended Data Fig. 5e ). Indeed, after feeding a DDC diet to Alb-cre
Hnf6 f/f R26ZG +/+ mice in which hepatocyte fate tracing was induced at >P120, we found that 84.5 ± 5.6% of the cells in reactive ductules originated from hepatocytes, in contrast to 20.1 ± 3.0% in Cre-negative littermates (Extended Data Fig. 5f ). These results confirm that NOTCH signalling is important for cholangiocyte proliferation 31 , which explains our finding of a limited role of proliferation in HpBD formation and underscores the authenticity of hepatocyte-derived peripheral cholangiocytes.
As illustrated by a lack of pBDs in Alb-cre (Fig. 1c) , NOTCH signalling is needed for bile duct development [7] [8] [9] , raising the question of which signalling pathway drives HpBD formation in its absence (Extended Data Fig. 4b, c) . We focused on TGFβ signalling because it promotes biliary differentiation and morphogenesis in development 32 , although it is not essential, as shown by the development of a normal biliary tree in mice that lack the TGFβ type II receptor (TGFBR2) in embryonic liver progenitors (Extended Data  Fig. 6a ). We reasoned that TGFβ signalling is induced in hepatocytes of Alb-cre
f/f mice because of the paradoxical role of HNF6 in liver development-it activates the biliary transcription factors HNF1β and SOX9 25, 33 , but inhibits TGFBR2 32, 34 . Indeed, Gene Ontology (GO) term enrichment analysis of our RNA-seq data suggested active TGFβ signalling in hepatocyte-derived peripheral cholangiocytes, but not in normal peripheral cholangiocytes (Supplementary Table 1 , down pC versus HpC). Moreover, we found high levels of phosphorylated SMAD3 (pSMAD3) in the nuclei of periportal HNF1-positive epithelial liver cells and in whole-liver nuclear extracts in Alb-cre
mice at P60 (Extended Data Fig. 6b, c) .
We functionally validated these findings by showing that the TGFβ inhibitor SB-431542 blocks biliary differentiation and morphogenesis of hepatocytes that lack RBPJ and HNF6 in vitro (Extended Data Fig. 6d-f) . Moreover, at >P120, HpBDs were still absent or severely truncated, and liver fibrosis persisted in 14 out of 16 Alb-cre
f/f mice, were cholestatic at P34-P53 (Fig. 3c, d and Extended Data Fig. 6c, g ).
These findings led us to investigate whether activating TGFβ signalling in hepatocytes enhances HpBD formation. We intravenously injected P19-P24 Alb-cre
f/f mice with an AAV serotype 8 vector expressing constitutively active TGFBR1 from the eukaryotic translation elongation factor 1α1 (Eef1a1) promoter (AAV8-Eef1a1-caTgfbr1). At P80-P100, 9 out of 11 treated mice had a mature hierarchical biliary network, whereas 9 out of 9 untreated mice still had an immature homogeneous biliary network 35 ( Fig. 3e ). Reflecting improved bile drainage, cholestasis and liver fibrosis resolved faster in treated mice (Fig. 3f, g ). We ruled out the possibility that AAV8-Eef1a1-caTgfbr1 is fibrogenic in Rbpj
f/f mice (Extended Data Fig. 6h ). These results identify TGFβ signalling as the driver of transdifferentiation and morphogenesis in HpBD formation.
To exclude the possibility that transdifferentiation is limited to immature hepatocytes, we investigated whether adult hepatocytes can form HpBDs. To bypass potential adaptive processes in development, we deleted Rbpj and Hnf6 and activated GFP in hepatocytes of P75 Rbpj f/f Hnf6 f/f R26ZG +/+ mice by co-injecting AAV8-Ttr-Cre and AAV8-Ttr-Flp and transplanted the cells 1 week later into P31 Alb-cre
Il2rg
−/− mice (Fig. 4a ). After P120, we found donor hepatocyte-derived mature peripheral cholangiocytes in 5.2 ± 0.8% of the portal areas containing donor cells (Fig. 4b) . We also transplanted NOTCH signalling-competent wild-type hepatocytes, which produced donor-derived HpBDs in 78. . g, Heat maps of genes reflecting hepatocyte differentiation, including all differentially expressed cytochrome P450 (CYP) genes enriched in adult mouse liver (top) and other marker genes (bottom). One-way ANOVA, false-discovery rate (FDR)-corrected P < 0.05; fold change > 3 (e-g). Two-sided Student's t-test; bold genes P < 0.05 for HpC versus pC (f, g).
Letter reSeArCH areas because 31.6 ± 7.9% of the transplanted cells proliferated after transdifferentiation into cholangiocytes (Fig. 4a, c, d ). These results show that adult hepatocytes, and transplanted hepatocytes, respond to the transdifferentiation-inducing and morphogenetic signals in the bile-duct-deficient liver and form HpBDs.
To determine whether our findings are relevant for human ALGS, we obtained liver samples from two patients who developed regenerative nodules containing pBDs 36 (Extended Data Table 1 ). The regenerative nodules contained CK7-positive pBDs, whereas nonregenerated liver tissue from the same patients showed abundant CK7-positive cells with hepatocyte morphology, indicative of metaplasia [14] [15] [16] [17] ( Fig. 4e) . To determine whether TGFβ signalling is active in the new pBDs, we used pSMAD3 immunofluorescence. We found nuclear localization of pSMAD3 in 56.1 ± 6.1% of the pBDs in regenerative nodules, but not in pBDs in normal human liver (Fig. 4f) . These results suggest that the TGFβ-mediated mechanism of HpBD formation identified in Alb-cre +/− Rbpj f/f Hnf6 f/f mice is also active in some patients with ALGS. 
Hnf6 f/f (n = 2) mice. Dotted lines represent the mean values of the indicated P120 mice from Extended Data Fig. 3f . e, f, Ink visualization of biliary tree and Sirius red staining with quantification in P100 Alb-cre 
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In conclusion, by showing that hepatocytes can convert into mature cholangiocytes and form a functional and stable biliary system, our findings establish that hepatocyte plasticity extends beyond metaplasia to transdifferentiation, and provide the first example, to our knowledge, of mammalian transdifferentiation building an organ structure de novo. Although hilar cholangiocytes are present in our mouse model, they fail to expand, resulting in severe cholestatic liver injury and strong pressure for hepatocytes to transdifferentiate into peripheral cholangiocytes. Analogously, cholangiocytes transdifferentiate into hepatocytes only when hepatocyte proliferation is completely suppressed 37 . The failure of hilar cholangiocytes to proliferate is probably caused by high TGFβ signalling in the cholestatic liver 38 . Accordingly, we identified TGFβ signalling as the driver of hepatocyte transdifferentiation and HpBD formation in our mouse model, and potentially also in patients with ALGS. Unlike for bile duct development [7] [8] [9] , NOTCH signalling is not needed. Using clinically established AAV vectors and hepatocyte transplantation, we show that our findings are potentially translatable into therapies for ALGS and other diseases associated with a lack of bile ducts.
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Il2rg
−/− mice. Male and female mice of the indicated age and genotype were chosen randomly for inclusion in experiments. The mouse used as a positive control for biliary gene expression was a C57BL/6 wild-type mouse fed choline-deficient diet (MP Biomedicals) and given 0.15% (w/v) ethionine (Sigma-Aldrich) in the drinking water (CDE diet) for 3 weeks. All mice were kept under barrier conditions. All procedures were approved by the Institutional Animal Care and Use Committee at UCSF or CCHMC. Adeno-associated virus. The AAV-Ttr-Flp plasmid was generated by removing Cre from AAV-Ttr-Cre 47 and replacing it with Flpo 48 from pPGKFlpobpA (Addgene 13793); viruses were produced by Vector Biolabs and used at a high dose of 1 × 10 12 -3 × 10 12 vg or low dose of 4 × 10 11 vg. The AAV-Eef1a1-caTgfbr1 plasmid was built by VectorBuilder to contain the activating T204D 49 mutation; virus was produced by Vector Biolabs and used at a dose of 1 × 10 11 vg. Titres were determined using qPCR. Viruses were delivered by tail vein injection in volumes ≤100 µl to prevent hydrodynamic effects.
Tissue collection. Livers from Alb-cre
and transplanted mice were perfused with ice-cold PBS followed by 4% paraformaldehyde (PFA). Samples were cut into slices and fixed overnight in 4% PFA at 4 °C.
Livers from R26R-RFP +/+
, Alb-cre
Hnf6
f/f and Alb-cre
+/+ mice were fixed overnight in 4% PFA at 4 °C. For thin sectioning, samples were moved to 30% sucrose overnight at 4 °C to cryopreserve and then embedded in OCT (Tissue-Tek) or processed for paraffin embedding and sectioning. A Leica CM3050 S cryostat was used to cut 6 µm cryosections for staining and imaging. For 3D and sparse-labelling clonal analysis, liver samples were embedded in 4% agarose and sectioned on a Leica VT100 S vibratome. For clonal analysis in R26R-Confetti +/− mice, liver samples were cut into 1 mm slivers, immunostained, washed in PBS, equilibrated in 30% sucrose and embedded in OCT. The 1 mm slivers were then cryosectioned at 100 µm, stained with Hoechst and mounted in PBS for confocal imaging. For analysis of Flp-based hepatocyte fate tracing in R26ZG +/+ mice, liver samples were fixed in neutral-buffered formalin containing zinc (Z-Fix, Anatech), embedded in paraffin and sectioned to 5 µm. Human liver tissue. Explant samples from the regenerative nodule and nonregenerated liver tissue of a 3-year-old male patient with ALGS were previously described; regenerative nodule and nonregenerated liver tissue contained the same heterozygous JAG1 exon 1-26 deletion
36
. Samples were obtained with patient consent and approval from the Commission Cantonale d'Ethique de la Recherché CCER. Biopsy samples from the regenerative nodule and nonregenerated liver tissue of a 15-year-old male patient with ALGS caused by a heterozygous c.499 T > A (p.W167R) JAG1 mutation and resection samples from a histologically normal region of the liver of a 35-year-old male undergoing surgery for metastasis of rectal adenocarcinoma were obtained with patient consent and approval from the UCSF Institutional Review Board. Immunostaining and histology. Cryosections were blocked in 10% normal serum and permeabilized in 0.3% Triton-X before staining with primary and secondary antibodies listed in Supplementary Tables 2 and 3 . Paraffin-embedded samples were deparaffinized and underwent antigen retrieval in sodium citrate buffer (Bio-Genex or Vector Labs) or Tris EDTA buffer (10 mM Tris Base, 1 mM EDTA, 0.05% Tween 20, pH 9.0) in a steamer or pressure cooker for 15 min before blocking and permeabilization. Thin sections were mounted in FluorSave (MilliporeSigma) or 50% glycerol. Vibratome sections were stained free-floating in 12-well dishes and cleared in Focus Clear (Cedarlane Laboratories) before being mounted in Mount Clear (Cedarlane Laboratories) for confocal imaging. All samples stained with anti-wsCK antibody underwent antigen retrieval in 100 mM Tris buffer (pH 9.5) at 55 °C for 2 h before blocking. Staining with anti-pSMAD3 antibody used a biotinylated secondary antibody followed by avidin/biotin-based peroxidase and tyramide amplification. Staining with anti-SSTR2 antibody used an HRP secondary antibody followed by tyramide-based amplification. M.O.M. Kit (Vector Laboratories) was used for antibodies raised in mice. DAPI or Hoechst was used to stain nuclear DNA. Chromogenic detection used a horseradish peroxidase (HRP) secondary antibody followed by avidin/biotin-based peroxidase amplification and DAB substrate exposure. Sirius red staining was performed on deparaffinized and rehydrated samples using a 0.1% Picrosirius red solution (Dudley Corporation and Newcomer Supply) and 0.5% acetic acid water washes or was done at Peninsula Histopathology Laboratory. Imaging. Thin sections were imaged on an Olympus BX51 upright microscope and cultured cells were imaged on an Olympus IX71 inverted microscope using Openlab software (PerkinElmer). Chromogenic stains were imaged on a Leica DM 1000 LED. Fiji 50 and/or Photoshop (Adobe) were used to process (brightness, contrast and gamma) and merge channels. Thick sections for 3D analysis of connectivity and clonal analysis were imaged on a Leica upright AOBS confocal microscope and processed and analysed using Imaris (Bitplane) or Volocity (PerkinElmer) software. For R26R-Confetti +/− mouse and pSMAD3 analysis, images were acquired using a Nikon A1R GaAsP inverted SP confocal microscope and NIS elements software and processed and analysed using Imaris software. Sirius red-stained sections were imaged using a Cytation 5 cell imaging multi-mode reader (BioTek). Ink injection. A catheter was inserted in a retrograde fashion into the common bile duct of post-mortem mice and waterproof ink (Higgins) was slowly injected. Left liver lobes were dehydrated in 1:1 methanol:water followed by 100% methanol. Ink was visualized by tissue clearing in 1:2 benzyl alcohol:benzyl benzoate (BABB) solution and imaged on a Leica M205A or Nikon SMZ800 stereoscope. Cholangiocyte isolation. Nonparenchymal liver cells were isolated from >P115 Alb-cre
Hnf6
f/f and Rbpj
Hnf6 f/f mice as previously described 51 . Cells were resuspended at 1 × 10 7 cells ml −1 in DMEM/2% FBS and blocked with Mouse Fc Block (BD Biosciences) for 30 min. Cells were incubated with fluorochromeconjugated antibodies (Supplementary Table 2 ) and DBA-FITC (Vector Laboratories) for 30 min, washed with cold Dulbecco's PBS (DPBS) three times and resuspended in DMEM/2% FBS. Sytox Red (Thermo Fisher Scientific) was added to label dead cells before sorting. Unstained and single-stained cells were used for compensation. Specificity of DBA binding was verified with a GalNAc (Sigma)-blocked control as previously described 52 . Cells were analysed and sorted on a FACSAria III using FACSDiva software (BD Biosciences). From the CD11b -
CD31
-CD45 -population, EPCAM + DBA -cells were collected as peripheral cholangiocytes and EPCAM + DBA + as hilar cholangiocytes. FlowJo (FlowJo, LLC) was used to analyse data and generate charts. Cells were either sorted into DMEM/2% FBS, pelleted and snap frozen, or sorted directly into extraction buffer for RNA purification. Hepatocyte isolation. Hepatocytes were isolated from >P115 Alb-cre
Hnf6
f/f mice by two-step collagenase (Worthington) perfusion followed by purification through a Percoll gradient. Cells were resuspended at 1 × 10 6 cells per 100 µl in Hanks buffer with 10% FBS and incubated with OC2-2F8 antibody (Supplementary Table 2 ) for 1 h on ice. Cells were washed with cold DPBS twice and resuspended in Hanks/10% FBS. Fluorochrome-conjugated secondary antibody (Supplementary Table 3 ) was added and cells were incubated for 30 min on ice followed by two washes with cold DPBS. Cells were blocked with 5% normal rat serum (Jackson Immuno) in Hanks buffer for 10 min on ice. Cells were then incubated with fluorochrome-conjugated antibodies (Supplementary Table 2) for 30 min on ice. Cells were then washed in cold DPBS three times and resuspended in Williams E medium/2% FBS. Sytox Red (Thermo Fisher Scientific) was added to label dead cells before sorting. Unstained and single-stained cells were used for compensation. Cells were analysed and sorted on a FACSAria III using FACSDiva software (BD Biosciences). From the CD11b
+ cells were collected as hepatocytes ( Supplementary Fig. 2 ). Cells were either sorted into DMEM/2% FBS, pelleted and snap frozen, or sorted directly into extraction buffer for RNA purification. Hepatocyte transplantation. Hepatocytes were isolated from donor mice by twostep collagenase perfusion followed by purification through a Percoll gradient. 1 × 10 6 viable cells were resuspended in 80-100 µl of Williams E medium with glutamine. Transplantation was performed by transdermal intrasplenic injection of the cell suspension under isoflurane anaesthesia. DDC diet feeding. Mice received PicoLab Mouse Diet 20, 5058 (LabDiet) with 0.1% 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC; Sigma-Aldrich) for the indicated durations. qPCR and gene expression analysis. Genomic DNA was isolated from cells using QIAamp DNA Micro Kit or DNeasy Blood & Tissue Kit (Qiagen). RNA was extracted using Trizol Reagent (Thermo Fisher Scientific) and purified by isopropanol precipitation (cells in collagen gel) or purified using RNAeasy Mini Kit (Qiagen) (liver tissue). Reverse transcription was performed using qScript cDNA Supermix (Quanta Biosciences). qPCR was performed using SYBR green reagent (Thermo Fisher Scientific) in a ViiA 7 system (Thermo Fisher Scientific). Reactions were performed in triplicate, and expression was normalized to an Rbpj Letter reSeArCH (genotyping) or Gapdh (gene expression) reference and quantified using the ΔΔC t method. Primers are listed in Supplementary Table 4 . RNA-seq. RNA was purified from FACS-isolated cells using PicoPure Kit (Thermo Fisher Scientific). RNA quality was assessed using RNA 6000 Pico Kit on a 2100 Bioanalyzer (Agilent). Samples with an RNA integrity number (RIN) ≥ 7.7 and at least 15 ng of RNA were used to construct sequencing libraries using Clontech Low Input Library Prep Kit v2. Libraries were sequenced on a HiSeq 3000, 10 samples per lane, with single-end 50 bp reads. Raw reads were aligned to the mm10 mouse genome with annotations provided by UCSC using CobWEB, a proprietary Burrows-Wheeler Transform method. Reads per kilobase per million (RPKM) were calculated from aligned reads using the expectation-maximization algorithm. RPKM was thresholded at 1, log 2 transformed, normalized using the DESeq algorithm and baselined to the median of all samples. Analyses were performed on transcripts with RPKM > 5 in all samples of at least 1 experimental condition (n = 17,793 transcripts). These reasonably expressed transcripts were used in principle component analysis. All transcripts with fold change > 3 in at least 1 of the 3 possible pairwise comparisons (n = 6,464) were selected, and a one-way ANOVA was performed to identify significantly differential genes with FDR-corrected P < 0.05 (n = 4,997). Venn diagrams were used to identify unique and shared gene signatures. Gene sets were submitted to https://ToppGene.cchmc. org for identification of pathway and biological process enrichments. Western blot. Nuclear and cytoplasmic extracts were generated from whole liver using previously described buffers with protease and phosphatase inhibitors 53 . Samples were run on SDS-PAGE 4-20% Tris-glycine gradient gels, electrophoretically transferred to nitrocellulose membrane and probed with antibodies. Signals were detected by ECL western blotting substrate (GE Healthcare). The membrane was stripped and reprobed with anti-actin antibody to verify and normalize protein loading using densitometry. Quantification was performed using ImageJ software. Serum chemistry. Blood was collected from post-mortem Alb-cre
Hnf6 f/f mice and controls of ages P20 to ≥P150 and tested for serum total bilirubin (TecoDiagnostics) and alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase (ADVIA XPT clinical chemistry system, Siemens). For serial bilirubin measurements, blood was collected by retro-orbital venipuncture and tested for total bilirubin every 2 weeks from P60 to P189 in four different litters. Blood was collected from Alb-cre
Tgfbr2
f/f mice and controls by retro-orbital venipuncture and tested for serum total bilirubin (TecoDiagnostics). Blood was collected from Alb-cre
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Extended Data Fig. 3 | HpBDs relieve cholestasis and liver injury. a, Serum total bilirubin levels in P20-P29 (n = 6), P30-P39 (n = 33), P40-P49 (n = 35), P50-P59 (n = 8), P60-P69 (n = 46), P70-P79 (n = 22), P80-P89 (n = 13), P90-P119 (n = 20), P120-P149 (n = 52) and ≥P150 (n = 40) Alb-cre +/− Rbpj f/f Hnf6 f/f and P20-P29 (n = 5), P30-P39 (n = 24), P40-P49 (n = 19), P50-P59 (n = 7), P60-P69 (n = 27), P70-P79 (n = 10), P80-P89 (n = 11), P90-P119 (n = 10), P120-P149 (n = 41) and ≥P150 (n = 25) Rbpj f/f Hnf6 f/f mice. **P = 0.0011 at P20-P29, ****P = 1.7 × 10 −13
at P30-P39, ****P = 8.2 × 10 −12 at P40-P49, ***P = 0.00019 at P50-P59, ****P = 8.4 × 10 −10 at P60-P69, ***P = 0.00055 at P70-P79, not significant (ns; P = 0.090) at P80-P89, not significant (P = 0.050) at P90-P119, not significant (P = 0.052) at P120-P149 and not significant (P = 0.064) at ≥P150, two-sided Welch's t-test. b, Serial measurements of serum total bilirubin levels in Alb-cre
and Rbpj f/f Hnf6 f/f (n = 5) mice. P = 0.11, two-sided Welch's t-test. c-e, Serum alkaline phosphatase (ALP), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in P43-P45 (n = 13), P69-P82 (n = 13), P120 (n = 14) and P150 (n = 11) Alb-cre +/− Rbpj f/f Hnf6 f/f and P43-P45
(n = 5), P69-P82 (n = 4), P120 (n = 9) and P150 (n = 6) Rbpj
Hnf6 f/f mice. In c: ****P = 0.000058 at P43-P45, ****P = 0.000019 at P69-P82, **P = 0.0064 at P120, not significant (P = 0.22) at P150 and ***P = 0.00010 at P120 versus P69-P82, two-way ANOVA followed by Holm-Sidak multiple comparison test. In d: **P = 0.0050 at P43-P45, not significant (P = 0.47) at P69-P82, not significant (P = 0.30) at P120 and not significant (P = 0.47) at P150, two-way ANOVA followed by HolmSidak multiple comparison test. In e: **P = 0.0024 at P43-P45, *P = 0.015 at P69-P82, ****P = 0.000073 at P120 and not significant (P = 0.061) at P150, two-way ANOVA followed by Holm-Sidak multiple comparison test. f, Sirius red staining in P15 (n = 9), P70-P90 (n = 7) and P120 (n = 6) Alb-cre +/− Rbpj f/f Hnf6 f/f and P15 (n = 5), P70-P90 (n = 3) and P120 (n = 3) Rbpj f/f Hnf6 f/f mice with quantification. Not significant (P = 0.94) at P15, ****P = 0.000095 at P70-P90, **P = 0.0074 at P120 and *P = 0.027 at P120 versus P70-90, two Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
Sample sizes of sufficient statistical power were chosen based on previously published studies using similar analyses (PMIDs 27210761, 24631193, 21282722, 22105172).
Data exclusions
Describe any data exclusions.
For ink injection, livers that were misinjected or improperly dehydrated were excluded. For RNA-seq, samples with RIN below 7.7 or RNA yield below 15 ng were excluded. For sparselabeling clonal analysis, clones that extended to and potentially beyond the x, y or z boundaries were excluded. For Sirius-red-staining quantification, tissue sections that were damaged or folded were excluded.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
For each series of experiments, attempts at replication were successful. A statement describing experimental replication for all figures is included in the Quantification and statistics section of the Methods.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Male and female mice of the indicated age and genotype were chosen randomly for inclusion in experiments, with the exception of RNA-seq where only female mice were used.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Researchers were not blinded when analyzing results. The hepatic phenotype of Alb-cre+/-Rbpjf/fHnf6f/f mice is distinguishable by gross examination. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided 
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Imaging: Thin sections and cultured cells were imaged using Openlab software (PerkinElmer). Fiji (ref. 50 ) and/or Photoshop (Adobe) software was used to process (brightness, contrast and gamma) and merge channels. Images of thick sections for 3D analysis of connectivity and clonal analysis were processed and analyzed using Imaris (Bitplane) or Volocity (PerkinElmer) software. For R26R-Confetti+/-mouse and pSMAD3 analysis, images were acquired using NIS elements software (Nikon Center of Excellence Confocal Imaging Core at CCHMC) and processed and analyzed using Imaris software. Gen5 Microplate Reader and Imager Software was used to capture images for Sirius-red-staining analysis on a Cytation 5 cell imaging multimode reader (BioTek).
Cholangiocyte and hepatocyte isolation: Cells were analyzed and sorted on a FACSAria III using FACSDiva software (BD Biosciences). FlowJo (FlowJo, LLC) was used to analyze data and generate charts.
RNA-seq: Raw reads were aligned to the mm10 mouse genome with annotations provided by UCSC using CobWEB, a proprietary Burrows-Wheeler Transform method.
Western blot: Quantification was performed using ImageJ.
Quantification and statistics: For clonal analysis in R26R-Confetti+/-mice, 30-40 μm z-stack images of wsCK-positive DBA-negative pBDs and wsCK-positive DBA-positive hBDs were visualized in 3D with Imaris software. The module Surfaces within Imaris was used to render a 3D surface created on an intensity value on a per channel basis. For Sirius-red-staining quantification, Fiji software was used to set a threshold for Sirius-red-positive area within each lobe and the percent of the total area that was Sirius red positive was measured and is reported. Charts were generated in Prism 6 or 7 (GraphPad).
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
All materials are commercially available, with the exception of unique materials, which are available from the authors on reasonable request.
